HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$41.94
Day range
$40.92 - $42.26
Year range
$7.10 - $50.78
Market cap
2.25B USD
Avg Volume
1.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 31.11M | -0.47% |
Net income | -28.38M | 5.61% |
Net profit margin | — | — |
Earnings per share | -0.56 | 30.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 403.66M | 104.75% |
Total assets | 419.36M | 100.07% |
Total liabilities | 65.81M | 26.82% |
Total equity | 353.54M | — |
Shares outstanding | 54.70M | — |
Price to book | 6.46 | — |
Return on assets | -26.15% | — |
Return on capital | -27.67% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -28.38M | 5.61% |
Cash from operations | -33.83M | -28.67% |
Cash from investing | -219.29M | -1,892.43% |
Cash from financing | 276.54M | 156.09% |
Net change in cash | 23.42M | -75.06% |
Free cash flow | -26.98M | -66.53% |
About
Founded
2016
Headquarters
Website
Employees
55